Noncontrast Chest Computed Tomographic Imaging of Obesity and the Metabolic Syndrome: Part I Cardiovascular Findings

Journal of Thoracic Imaging
Christopher L SchlettRepresenting the International Workshop for Pulmonary Functional Imaging (IWPFI)

Abstract

There are physiological consequences of overeating that can lead to increased morbidity and mortality. The purpose of this review article is to acquaint the reader with the current state of the art in the non-cardiac-gated, noncontrast chest computed tomographic (NCCT) imaging biomarkers of the metabolic syndrome and their prognostic significance found in the lower neck and chest. NCCT imaging biomarkers associated with metabolic syndrome in the chest include premature coronary artery calcification, acceleration of large vessel arterial and valvular calcifications associated with atherosclerosis, and pulmonary arterial enlargement from pulmonary hypertension associated with sleep apnea. These easily identified imaging biomarkers have prognostic implications for major adverse cardiac events (MACE). These NCCT chest-imaging biomarkers are likely targets for artificial intelligence algorithms to harvest for longitudinal assessment of their individual and multifactorial contributions to chronic disease, MACE, and mortality. Early recognition and treatment of these common disorders may help improve patient outcomes and quality of life while decreasing medical costs.

References

Nov 7, 2000·The British Journal of Radiology·S J BrownR A Coulden
Mar 26, 2003·Circulation·Caroline S FoxUNKNOWN Framingham Heart Study
Mar 25, 2005·AJR. American Journal of Roentgenology·Sheung-Fat KoTze-Yu Lee
Apr 20, 2005·Lancet·Robert H EckelPaul Z Zimmet
May 20, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Kevin D O'Brien
Apr 24, 2007·AJR. American Journal of Roentgenology·Andreas H MahnkenRalf Koos
Sep 27, 2007·European Journal of Epidemiology·Armin ImhofWolfgang Koenig
Dec 6, 2007·The Canadian Journal of Cardiology·Patrick MathieuP Pibarot
Mar 22, 2008·AJR. American Journal of Roentgenology·Sung Mok KimBong-Keun Choe
Mar 28, 2008·The New England Journal of Medicine·Robert DetranoRichard A Kronmal
Oct 22, 2009·AJR. American Journal of Roentgenology·Maria d'Almeida BastosPhillip M Boiselle
Oct 16, 2010·Journal of the American College of Cardiology·Raimund ErbelUNKNOWN Heinz Nixdorf Recall Study Investigative Group
Nov 9, 2010·European Radiology·Martijn J A GondrieUNKNOWN PROVIDI Study Group
Nov 26, 2010·Circulation·Philip GreenlandUNKNOWN American College of Cardiology Foundation/American Heart Asscoiation Tasl Force on Practice Guidelines
Aug 23, 2012·JAMA : the Journal of the American Medical Association·Joseph YeboahDavid M Herrington
Sep 18, 2012·Journal of Cardiovascular Computed Tomography·Paul Madaj, Matthew J Budoff
Jun 19, 2013·JACC. Cardiovascular Imaging·Onno M MetsPim A de Jong
Jan 16, 2014·Journal of Applied Clinical Medical Physics·Atsushi FukudaTosiaki Miyati
Jan 30, 2014·Thorax·Michelle C WilliamsUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators
Mar 7, 2014·Academic Radiology·Neal CorsonMardi Gomberg-Maitland
Mar 13, 2014·The International Journal of Cardiovascular Imaging·Katherine J BlairJoachim H Ix
Sep 10, 2014·Sleep·Andrew M KimRichard J Schwab
Sep 24, 2014·AJR. American Journal of Roentgenology·Atul PadoleMannudeep Kalra
Dec 6, 2014·Magnetic Resonance Imaging Clinics of North America·Maurice B BizinoHildebrandus J Lamb
Apr 22, 2015·European Heart Journal Cardiovascular Imaging·Olli HartialaOlli T Raitakari
May 13, 2015·The International Journal of Cardiovascular Imaging·Martin J WilleminkPim A de Jong
Aug 26, 2015·European Radiology·Robert C BertheauChristopher L Schlett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.